GenAIwings
——
GenAIwings started providing enzyme solutions in 2021, with the aim of being the pioneer in providing enzyme solutions. Our core value is "Technology Leads the Innovation", and we are dedicated to advancing the industrial upgradation and product innovation via combining the AI technology with the enzyme R&D process. Our product portfolio covers biopharma, food and nutrition, at the core of an AI-enabled model, from strain design and construction, process development and validation, to the commercial scale-up. We have an ISO90001-compliant facility and manufacturing base.
Our product series includes Recombinant Enterokinase, Recombinant Carboxypeptidase B, Recombinant Kex2 Protease, Protein A Affinity Resin, and Maltogenic Amylases.
Our vision is to become the enzyme industrial innovation leader, providing a better, environment-friendly, and effective solution to our clients, making mutual progress in biotechnology and a sustainable earth.